Author:
Šenolt Ladislav,Vencovský Jiří,Pavelka Karel,Ospelt Caroline,Gay Steffen
Subject
Immunology,Immunology and Allergy
Reference40 articles.
1. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action;Bayry;Nat Clin Pract Rheumatol,2007
2. Is there a future for small molecule drugs in the treatment of rheumatic diseases?;Stanczyk;Curr Opin Rheumatol,2008
3. Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study;Kay;Arthritis Rheum,2008
4. Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study;Keystone;Arthritis Rheum,2008
5. N. Ruperto, P. Quartier, N. Wulffraat, et al., ACZ885 (canakinumab), A New Il-1 Beta Blocking Monoclonal Antibody Has A Beneficial Effect In Children With Systemic Juvenile Idiopathic Arthritis (sjia). In: Abstracts of the 2008 annual scientific meeting of the American college of Rheumatology; San Francisco, CA.
Cited by
104 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献